A Quality of Life Study of Peginterferon-Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C and Persistently Normal Alanine Transaminase (ALT) Levels

NCT02726022 · clinicaltrials.gov ↗

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Ribavirin

Sponsor

Hoffmann-La Roche